Cargando…

A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics

Cytotoxicity assays of immortalized lymphoblastoid cell lines (LCLs) represent a promising new in vitro approach in pharmacogenomics research. However, previous studies employing LCLs in gene mapping have used simple association methods, which may not adequately capture the true differences in non-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Chad, Havener, Tammy M., Everitt, Lorraine, McLeod, Howard, Motsinger-Reif, Alison A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268638/ https://www.ncbi.nlm.nih.gov/pubmed/22303380 http://dx.doi.org/10.3389/fgene.2011.00086

Ejemplares similares

Multivariate methods and software for association mapping in dose‐response genome‐wide association studies
por: Brown, Chad C, et al.
Publicado: (2012)

Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019)

Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees
por: Watson, Venita Gresham, et al.
Publicado: (2011)

The influence of Neanderthal alleles on cytotoxic response
por: Akhtari, Farida S., et al.
Publicado: (2018)

Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy
por: Small, George W., et al.
Publicado: (2023)

Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014)

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014)

Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial
por: Marvel, Skylar W., et al.
Publicado: (2017)

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response
por: Graham, Hillary T., et al.
Publicado: (2016)

Evaluation of calling algorithms for array-CGH
por: Roy, Siddharth, et al.
Publicado: (2013)

Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium
por: Che, Ronglin, et al.
Publicado: (2013)

Multifactor Dimensionality Reduction as a Filter-Based Approach for Genome Wide Association Studies
por: Oki, Noffisat O., et al.
Publicado: (2011)

High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs
por: Akhtari, Farida S., et al.
Publicado: (2021)

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients
por: Gonzalez, Ricardo D., et al.
Publicado: (2023)

RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients
por: Gonzalez, Ricardo D., et al.
Publicado: (2023)

Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022)

Addressing disparities in pharmacogenomics through rural and underserved workforce education
por: Brown, Jacob T., et al.
Publicado: (2023)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Pharmacogenomics and health disparities, are we helping?
por: Shaaban, Sherin, et al.
Publicado: (2023)

Gene set analysis methods: a systematic comparison
por: Mathur, Ravi, et al.
Publicado: (2018)

Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019)

A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity
por: Gory, Jeffrey J, et al.
Publicado: (2012)

Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021)

Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2021)

Beyond IC(50)s: Towards Robust Statistical Methods for in vitro Association Studies
por: Beam, Andrew, et al.
Publicado: (2014)

Race/ethnicity-stratified fine-mapping of the MHC locus reveals genetic variants associated with late-onset asthma
por: Lee, Eunice Y., et al.
Publicado: (2023)

Calculation of the pharmacogenomics benefit score for patients with medication-related problems
por: Polasek, Thomas M.
Publicado: (2023)

Multifactor dimensionality reduction: An analysis strategy for modelling and detecting gene - gene interactions in human genetics and pharmacogenomics studies
por: Motsinger, Alison A, et al.
Publicado: (2006)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
por: Abdelhalim, Habiba, et al.
Publicado: (2022)

Editorial: The role of pharmacogenomics in addressing health disparities: the path, the promise, and the barriers
por: Roman, Youssef M.
Publicado: (2023)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
por: Simona, Aurélien, et al.
Publicado: (2023)

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
por: Mroz, Pawel, et al.
Publicado: (2021)

An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use
por: Che, Ronglin, et al.
Publicado: (2014)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report
por: Prather, April, et al.
Publicado: (2022)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States
por: Sun, Boguang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o735q0igfcpnbo0jjdg267halv